Onabotulinum toxin A 100 U in cases of idiopathic overactive bladder

The National Health Care Institute concluded that treatment with onabotulin toxin A 100 U does comply with the established medical science and medical practice criterion for insured patients with idiopathic overactive bladder.

This report is a summary of recommendations by the National Health Care Institute. The original text is in Dutch.